# Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)

Source: https://welltoldgrants.com/grants/rfa-ca-22-022-early-stage-development-of-informatics-technologies-for/  
Official notice: https://www.grants.gov/search-results-detail/338916

> National Institutes of Health offered grants to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. Applications closed on November 17, 2022.

| Field | Value |
|---|---|
| Opportunity number | RFA-CA-22-022 |
| Agency | National Institutes of Health |
| Status | Forecast |
| Deadline | November 17, 2022 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | not stated |
| Total funding | not stated |
| Cost sharing | not required |
| Assistance Listings | 93.393, 93.394, 93.395, 93.396, 93.399 |

## Who can apply

- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

## What the grant funds

The goal of this FOA is to advance cancer model systems that recapitulate human immunity in the tumor microenvironment to improve the predictivity of immuno-oncology studies. Proposed research projects must focus on recapitulation of the human immune system in their proposed cancer model using human cells or tissues to regenerate and/or recapitulate the human immune system in in vivo or in vitro immuno-oncology models in a manner that matches or exceeds representation of the human immune system achieved with murine models developed using HFT. Models derived from genetically manipulated immune systems without introduction of human immune lineage cells will not be considered responsive. The FOA will utilize the R33 Exploratory/Developmental Grants Phase II research activity code.

## Questions people ask

### Is RFA-CA-22-022 still open?

No. It closed on November 17, 2022. A newer notice is open: RFA-CA-27-019, closes October 19, 2027 (346 days left).

### Who can apply for Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)?

National Institutes of Health accepted applications from nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)?

Closed November 17, 2022. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### Who has been funded under RFA-CA-22-022?

NIH RePORTER lists 6 projects funded under RFA-CA-22-022 in fiscal 2023 to 2025, at 6 institutions. The most were at University of Pittsburgh at Pittsburgh, University of Virginia, Harvard Medical School.

### Who has won Cancer Cause and Prevention Research grants before?

The largest recipients over five fiscal years were The Univeristy of Texas M.D. Anderson Cancer Center, Sloan-Kettering Institute for Cancer Research, The Trustees of Columbia University in the City of New York. The program made 2,517 awards worth $3.6 billion in that time.